Literature DB >> 7996853

Interactions of mitochondrial ATP synthesis and the creatine kinase equilibrium in skeletal muscle.

G J Kemp1.   

Abstract

In skeletal muscle, creatine kinase imposes constraints on the concentrations of phosphocreatine, creatine, ATP and ADP, which complicate our understanding of the regulation of mitochondrial ATP synthesis, because correlations between oxidation rate (Q) and metabolite concentrations cannot prove causal relations. Two kinds of theory of mitochondrial control in vivo have evolved, based on (i) the hyperbolic relationship between Q and cytosolic [ADP] and (ii) linear correlations between Q and, for example, free energy of ATP hydrolysis. This paper examines some relationships between these theories in order to show (i) to what extent they may be regarded as different expressions of the same metabolic mechanisms, (ii) how they can be understood in terms of general principles of feedback control, and (iii) how they explain relationships between mitochondrial function and resting metabolite concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996853     DOI: 10.1006/jtbi.1994.1184

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  11 in total

1.  Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy.

Authors:  G J Kemp; M Roussel; D Bendahan; Y Le Fur; P J Cozzone
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

2.  Implications of rapid early oxygen consumption in exercising skeletal muscle.

Authors:  Graham Kemp
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

3.  Muscle oxygenation and ATP turnover when blood flow is impaired by vascular disease.

Authors:  G J Kemp; N Roberts; W E Bimson; A Bakran; S P Frostick
Journal:  Mol Biol Rep       Date:  2002       Impact factor: 2.316

4.  Dominant and sensitive control of oxidative flux by the ATP-ADP carrier in human skeletal muscle mitochondria: Effect of lysine acetylation.

Authors:  W T Willis; D Miranda-Grandjean; J Hudgens; E A Willis; J Finlayson; E A De Filippis; R Zapata Bustos; P R Langlais; C Mielke; L J Mandarino
Journal:  Arch Biochem Biophys       Date:  2018-04-10       Impact factor: 4.013

5.  Theoretical modelling of some spatial and temporal aspects of the mitochondrion/creatine kinase/myofibril system in muscle.

Authors:  G J Kemp; D N Manners; J F Clark; M E Bastin; G K Radda
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

6.  A theoretical model of some spatial and temporal aspects of the mitochondrion creatine kinase myofibril system in muscle.

Authors:  G J Kemp; D N Manners; J F Clark; M E Bastin; G K Radda
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

7.  Effect of creatine on aerobic and anaerobic metabolism in skeletal muscle in swimmers.

Authors:  C H Thompson; G J Kemp; A L Sanderson; R M Dixon; P Styles; D J Taylor; G K Radda
Journal:  Br J Sports Med       Date:  1996-09       Impact factor: 13.800

8.  Physiological constraints on changes in pH and phosphorus metabolite concentrations in ischemically exercising muscle: implications for metabolic control and for the interpretation of 31P-magnetic resonance spectroscopic studies.

Authors:  G J Kemp
Journal:  MAGMA       Date:  1997-09       Impact factor: 2.310

9.  Evaluation of metabolomic changes as a biomarker of chondrogenic differentiation in 3D-cultured human mesenchymal stem cells using proton (1H) nuclear magnetic resonance spectroscopy.

Authors:  Moo-Young Jang; Song-I Chun; Chi-Woong Mun; Kwan Soo Hong; Jung-Woog Shin
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

10.  Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.

Authors:  C H Thompson; V M Macaulay; K J O'Byrne; G J Kemp; S M Wilner; D C Talbot; A L Harris; G K Radda
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.